Search This Blog

Saturday, July 4, 2026

Tusk: We expect Kyiv to explain Nazi-tied scandal

 Polish Prime Minister Donald Tusk told reporters on Saturday that Warsaw expects Kyiv to "take the first step" and explain the recent scandal tied to Nazi glorification.

"It would be good to hear a clear signal from Kyiv. They are trying, but we would like to hear it clearly," he said, adding that "there are objective reasons for this tension. And one of these reasons, as we know from our own history, is the difficulty of coming to terms with one's own history."

The relationship between the two neighbors got strained in May after Ukrainian President Volodymyr Zelensky attended the reburial of the remains of Andriy Melnyk, who cooperated with Nazi intelligence during the German invasion of Poland in 1939. Polish President Karol Nawrocki reacted by stripping Zelensky of the Polish Order of White Eagle.

https://breakingthenews.net/Article/Tusk:-We-expect-Kyiv-to-explain-Nazi-tied-scandal/66632463

AI Doesn’t Just Misinform Patients. It Gives Them a Plausible Story

 A patient in her 50s came to my eye clinic for flashes of light in one eye. Before she sat down, she told me, calmly, that she already knew what this was: migraine with visual aura. She had worked it out with ChatGPT over several days. By the time I met her, her story had acquired the language of aura: a shimmer, a zigzag, something like a 20-minute spread, perhaps a mild discomfort behind her eye afterward. But on exam, I found a retinal tear. She would need laser treatment that day to protect her vision.

When I asked her to go back to the beginning (what had she noticed before she typed anything into ChatGPT?), the aura story began to fall apart. The original symptoms were briefer, peripheral, recurrent flashes, especially noticeable in the dark. The chatbot hadn't just fabricated a total falsehood but had done something more subtle: it had offered a plausible template, asked questions in that template's language, and helped her fit ambiguous memories into the wrong disease.

The usual worry about patients and artificial intelligence (AI) is that the chatbot will tell them something untrue. That concern is real, but it was just part of what had nearly cost this patient her vision. The more important issue here was the coherence of the story. Generative AI typically does not hand patients 10 conflicting links as Google searches used to. It returns a single fluent account, with an onset, a mechanism, and a conclusion, and then it refines that account in conversation until everything fits.

This is not a fringe scenario. In a 2026 KFF poll, 32% of U.S. adults said they had used AI chatbots for health information in the past year, and many who asked about physical or mental health did not follow up with a clinician afterward. Physicians increasingly describe spending much of a short appointment walking patients back from what a chatbot told them. Coherence is persuasive on its own.

The Google-era patient arrived with fragments. That ambiguity kept the question open for the clinician. The AI-era patient arrives with a conclusive narrative, based on a chatbot dialogue that offered something web search never did. It asks leading questions and folds the answers back in, so the story tightens with every exchange.

"Did the flashing zigzag across your vision?"

"Did it last around 20 minutes?"

"Was there a headache afterward?"

Each agreeable prompt invites the patient to supply a detail that was not there before.

This is where it stops being an information problem and becomes a memory problem. In a 2024 study from MIT and the University of California-Irvine, people who recalled an event through a back-and-forth with a generative chatbot formed more than three times as many false memories as a control group, and their confidence in those false memories stayed elevated a week later. Psychologist Elizabeth Loftus, PhD, a co-author of the study, has spent her career showing how suggestion reshapes recollection. The mechanism she describes is the one I now see in clinic: a suggestible patient, a fluent and agreeable interlocutor, leading questions, and a story that cements into memory. That's why I ended up spending so much time trying to separate what my patient had experienced from what the conversation had taught her to remember.

And the anchoring does not stop with the patient. A clean, confident narrative primes the clinician too. In a randomized clinical vignette study in JAMA, clinicians became significantly less accurate when shown biased AI diagnostic predictions, even when the model's explanations were displayed. Premature AI assumptions are dangerous precisely because they can act on both sides of the encounter.

The response to this issue should play out in three ways.

In the exam room, clinicians should ask patients if they have any thoughts or conclusions about their condition, and where those ideas came from. If the patient mentions use of an AI tool, clinicians should learn to re-elicit the original symptoms without borrowing the AI's vocabulary. This is why chatbot use belongs in the social history.

For patients, the safest use of AI is not "What do I have?" but "What symptoms should I not ignore and what should I ask my clinician?" A chatbot should help prepare the visit, not finish it.

For companies and policymakers, consumer health AI should be built to preserve uncertainty and tested in real use cases, not just model-only settings. In a 2026 Nature Medicine study, members of the public using large language models were no better than controls at identifying relevant conditions or choosing the right course of action, even though the models performed much better when tested alone. These systems should show a differential, avoid leading questions, identify red flags, and push toward evaluation when vision, chest pain, neurologic symptoms, pregnancy, suicidality, or other high-risk contexts are involved.

My patient kept her vision because the exam contradicted the story she had come to believe about her own eye. That is a thin margin. The next patient may bring a story so smooth that I am tempted to trust it, or they may have rehearsed it so many times that even careful questioning cannot fully uncover what really happened.

We have spent 2 years worrying that AI will tell patients things that are wrong. The harder, more insidious problem is that it will tell them things that are coherent and that they will remember the coherent version as the truth. Our job is no longer only to correct the record. It is to find out who wrote it.

https://www.medpagetoday.com/opinion/second-opinions/121988

AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure

 Authors: Mary Norine Walsh, Lars Kober, Karen Sliwa, Marianna Adamo, Anubha Agarwal, Amitava Banerjee, Biykem Bozkurt, Show All

Abstract

Heart failure (HF) remains a pressing health concern, with rising prevalence globally. Subjectivity and ambiguity in the definition of HF and its antecedent stages have limited research, global surveillance, and prevention programs. To address this, several cardiac societies and foundations convened to standardize the definition of HF in 2021 and designated stage B or pre-HF to identify individuals at risk of developing HF. In subsequent years, substantial progress and changes have been made in aspects of preventing HF, improving HF diagnosis and management, and recognizing the importance of the affected individual’s voice. Global differences and disparities in HF are better understood, as are causes and comorbidities leading to differences in care, which are also influenced by access to care. This consensus document presents the Second Universal Definition of Heart Failure, aiming to standardize terminology and facilitate a uniform approach for clinicians, researchers, health systems, and policymakers. In this definition, the classification of HF phenotypes moves away from rigid left ventricular ejection fraction cutoffs, instead grouping HF into reduced, preserved, and improved ejection fraction categories to better reflect clinical realities. A universal classification of HF causes is also proposed. The document also addresses the dynamic trajectories of HF—improvement, remission, and recovery—and highlights the impact of social determinants and geographic variation on HF risk and outcomes. By providing a comprehensive, standardized framework for HF definition and classification, this document seeks to improve prevention, early detection, and management of HF worldwide, ultimately enhancing patient care and advancing global cardiovascular health.

Universal definitions of clinical syndromes have been instrumental in guiding diagnosis by describing a combination of symptoms, biomarkers, imaging studies, and pathology that clearly characterize the syndrome. The first Universal Definition and Classification of Heart Failure1 clarified definitions of heart failure (HF) that had previously been ambiguous, poorly understood, and lacking in standardization.
Since then, the incidence and prevalence of HF, particularly among individuals with preserved ejection fraction (HFpEF), have continued to increase, as has the risk of HF hospitalization and mortality.2,3 The growing prevalence of HF is driven by the increasing numbers of individuals with HFpEF, the aging of the population, and secular trends in the prevalence of comorbidities that drive HF risk. In addition, advances in technology and the development of more advanced imaging methods (magnetic resonance imaging, positron emission tomography), allowing earlier and more accurate disease detection, along with improvements in survival resulting from the availability of expanded treatment options, have increased prevalence. Improved strategies for early diagnosis of HF leveraging artificial intelligence may enhance HF detection even further over traditional biomarker- and imaging-based approaches, making estimates of the total population-level HF burden more accurate.
Definitions of HF, including participant inclusion criteria, vary widely in HF clinical trials. Specifically, requirements for inclusion of only narrow ranges of left ventricular ejection fraction (LVEF) often obscure possible benefits of therapies for HF phenotypes that range outside that criterion.4
The identification of more diverse phenotypes of HF is rapidly expanding as a result of improvements in and greater availability of advanced imaging technologies. Routine genetic screening—as ease of testing has increased and cost has decreased—has brought new understanding of genetic and familial cardiomyopathies to the clinic and to many more patients and families. In addition, the impact of comorbid diseases and their therapies on HF phenotypes has made the accurate identification of such phenotypes crucial to aid in appropriate and effective therapies. The development and greater availability of HF treatments that are specific to HF phenotype drive the necessity for accurate identification and diagnosis.
Disparities in HF care are present worldwide, with access to diagnosis and quality treatment being influenced by race, ethnicity, sex, income, geography, access to and coverage of health care, and socioeconomic status.5 These disparities in care are particularly concerning for high-risk, underserved groups, who have the highest risk for HF hospitalization and death.6,7
These considerations underscore the need for the current update. As with other universal definitions such as that of myocardial infarction,8 the impetus for this updated document is to address changes in disease manifestations, diagnostic strategies, and understanding of pathophysiology. The current document serves as an update of the first definition1 with collaboration by the American College of Cardiology, the American Heart Association, the European Society of Cardiology, and the World Heart Federation. This document is not a clinical practice guideline, nor is it a clinical decision support document. Treatment recommendations will remain reserved for the current and future professional society HF guidelines documents.9,10

Proposed Changes in the Definition: Classification, Phenotypes, and Trajectories

Definition of HF Syndrome

As outlined in the first Universal Definition of Heart Failure,1 HF is a clinical syndrome with diverse causes characterized by the presence of typical symptoms, physical examination signs, and laboratory or imaging abnormalities suggestive of pulmonary or systemic congestion or changes in cardiac output that can be attributed to an underlying structural or functional cardiac abnormality. Clinical symptoms and signs of HF include dyspnea on exertion, orthopnea, jugular venous distention, rales, S3 gallop, and abdominal and leg swelling. Diagnostic certainty is amplified by confirmatory elevation in natriuretic peptide (BNP [B-type natriuretic peptide] or NT-BNP [N-terminal B-type natriuretic peptide]) levels or imaging evidence (lung ultrasound, chest radiography, echocardiography, computed tomography) of pulmonary congestion and elevated intracardiac filling pressures. It is important to note that HF is defined by the accumulation of suggestive features in a comprehensive assessment rather than by a single diagnostic test. As an example, a substantial proportion of individuals with HFpEF have normal natriuretic peptide levels despite unequivocal invasive hemodynamic evidence of HF, for example, elevation of ventricular filling pressure at rest or exercise.11,12 When HF is suspected, imaging is important to evaluate for structural or functional cardiac abnormalities that may inform the cause of HF and help guide the approach to treatment.

Permanence of the Diagnosis/Condition

As outlined in the first Universal Definition of Heart Failure,1 HF progresses in stages from those at risk (stage A) to those with structural heart disease (pre-HF or stage B), those with symptomatic HF (stage C), and those with advanced disease (stage D). Once a diagnosis of symptomatic HF is established, individuals with HF are generally considered to have the diagnosis permanently, even if the clinical condition improves with treatment.
For the purpose of selecting medical treatment, individuals with HF are commonly segregated by LVEF into those with preserved or mildly reduced ejection fraction (EF) and those with reduced EF. There are limitations to phenotype categorization by EF alone (or by specific cutoff values for EF), and there is evolving evidence for the efficacy and safety of therapies across different EF ranges. Acknowledging that EF may change with effective HF treatment, current guidelines recognize a separate subgroup of individuals whose EF increases with time and medical intervention as a separate category of HF with “improved” EF, emphasizing that these individuals may still be at risk for HF events. Although contention remains about the precise numeric thresholds of EF that should be used for HF phenotyping,13 it is essential to recognize the clinical relevance of incorporating the individual’s trajectory in determining the optimal approach to guideline-directed medical therapy and prognosis.

Definition and Criteria for Stages of HF

The first Universal Definition and Classification of Heart Failure1 reviewed the American Heart Association/American College of Cardiology staging system10 and renamed stage B as pre-HF, emphasizing early detection, close monitoring, and proactive management to prevent symptomatic HF.10,14 This consensus reaffirms the first Universal Definition and Classification of Heart Failure staging system, as shown in Table 1.

'AP: Alibaba to Pay $600M Over Allegations of Illegal Pharmaceutical Sales in the U.S.'

 The Chinese tech giant Alibaba will pay $600 million to resolve a dispute with the U.S. government over allegations that the Hangzhou-based firm sold and imported illegal pharmaceuticals, controlled substances, regulated chemicals, and pill-making equipment into the U.S.

Alibaba operates some of the world's largest e-commerce platforms, including Alibaba.com and AliExpress.com.

The U.S. alleges that Alibaba's U.S.-based payment processor, AUS Merchant Services, violated federal law by failing to prevent merchants from selling and importing illegal products into the U.S. through Alibaba.com and AliExpress.com.

Alibaba acknowledges in an agreement with the Justice Department that between January 2016 and December 2024, it failed to stop roughly 80,000 product sales involving unlawful imports that violated the Federal Food, Drug, and Cosmetic Act and other federal laws.

A news release on the settlement resolution says that Alibaba employees raised concerns that the company's compliance controls were inadequate and failed to prevent the sale of illegal products -- and, in some instances, merchants used Alibaba's messaging service to direct buyers to third-party messaging platforms to facilitate illegal sales.

In a statement, Alibaba said the firm and the U.S. government reached a mutually satisfactory resolution to bring stricter compliance to the sale of products in the U.S. by third-party merchants on its e-commerce platforms.

Law enforcement officers across the FDA, FDIC, IRS-Criminal Investigation, and other agencies conducted more than 40 undercover purchases of pharmaceuticals and equipment that were illegal to import into the U.S., according to the news release. A non-prosecution agreement was crafted between Alibaba and the Justice Department.

IRS Criminal Investigations' Chief Jarod Koopman said the resolution "underscores IRS Criminal Investigation's commitment to following the money and ensuring that companies operating in the United States comply fully with federal law."

https://www.medpagetoday.com/washington-watch/washington-watch/122026

Tinder activity surges by 34% in NYC, NJ during World Cup — most lovebirds international

 They’re trying to score.

Tinder users in New York City and New Jersey are having a ball with the influx of visitors to MetLife Stadium for the World Cup.

The dating app told The Post it has seen a 34% increase in non-local users in the area compared to the same time last year.

The international tourists using the app in the metro area hail mostly from the UK, Norway and Canada, while Americans coming to the area are mostly from Miami, Los Angeles and Boston, Tinder said.

Couple holding hands and walking through the empty stadium after a game.
Tinder reported there’s been a 34% increase in non-locals using the app in NYC and NJ during the World Cup.motortion – stock.adobe.com

On June 13, when Brazil played Morocco at MetLife Stadium, Tinder experienced a 35% lift in the area.

At the start of the soccer tournament, Tinder witnessed an average increase of over 47% from international users in the 16 host cities and a 22% lift among domestic visitors.

Swipe activity across World Cup host cities increased an average of almost 25%, Tinder said.

The top three host cities with the biggest surge in Tinder activity around World Cup games were Monterrey, Mexico, which enjoyed an 80% lift around the Sweden vs. Tunisia matchup; Guadalajara, Mexico, which had a 74% surge when South Korea played Czechia; and Boston, which saw a 47% increase during the Iraq vs. Norway game.

Influencer Kayla Rose, who has gone viral on Instagram for her World Cup dating posts, explained to single women in host cities that they should download Tinder to attract “cute foreign men.”

Women flooded the Bostonian’s comments section,

“This is so true! My cousin lives in Spain and the only dating app people outside the US really use is Tinder. Not just for hookups too but like actually dating and relationships,” one wrote.

“Tinder has a bigger fan base in Europe. I always use it when traveling overseas!!” another confirmed.

“I met my foreign husband on Tinder,” someone else added.

Other ladies who had already sworn off Tinder, also weighed in, pondering giving it another try.

“Yoooooo stop I am dying because i really don’t want to download tinder but I need a love story,” one said.

A few others predicted a baby boom next year.

“The birth rate in all these cities is going to be nuts 40 weeks from now,” one guessed.

Someone sympathized with local men who might lose out on love as local women seek foreign studs.

“American men . . . fake an accent,” they advised.

https://nypost.com/2026/07/04/us-news/tinder-activity-surges-by-34-in-nyc-new-jersey-during-world-cup/

Nearly a dozen members of Soros clan pouring money into House and Senate midterm races

 Nearly a dozen members of the wealthy Soros family collectively poured more than $1.6 million to Congressional candidates’ midterm campaigns so far, The Post has learned.

The donations suggest the clan’s grip on American politics extends even beyond patriarch George Soros and his son Alex, who took control of his father’s $25 billion empire ahead of the 2024 presidential election.

Topping the list of the other members of the clan was George’s son from his first marriage, Jonathan Soros and his wife Jennifer Allan Soros, who together donated $380,000 to House and Senate races all over the country.

Jonathan Soros and his wife Jennifer Allan Soros together donated $380,000 to House and Senate races.Evan Agostini/Invision/AP

Jonathan, 55, a Harvard law graduate who runs private investment firm One Madison Group and was snubbed as heir to the family business for his younger half-brother, met Jennifer, 56, when they were working on Bill Clinton’s 1992 presidential campaign and both have been active behind the scenes ever since.

His sister, Andrea Soros, George’s daughter from his first marriage, who just this week sold a luxurious $46 million mansion in tony West Village’s trendy West 4th Street, has also written checks to leftist candidates the tune of $26,000 so far these midterms.

Andrea, 61, whose husband Eric Colombel runs a Buddhism nonprofit empire, was named No. 2 in “top 10 richest billionaire heiresses” in 2010, with a $14 billion fortune, behind only Michael Bloomberg’s daughter Emma.

A favorite of the only Soros daughter — whose real estate portfolio also includes a sprawling house on 60 acres in Rhinebeck, NY, where Hillary and Chelsea Clinton have stayed — is potential 2028 Democratic presidential nominee Jon Ossoff, to whom she sent $14,000 so far this cycle.

Robert Soros and wife Jennifer Singer Soros together shelled out $40,200 on midterm races so far.Getty Images

Other politically influential members of the bloodline include George’s oldest son, Robert Soros and his new wife, socialite Jamie Singer Soros, who together donated $40,200.

Singer Soros, 41, who sits on the board of trustees of the Met and jet sets to Turks and Caicos, Paris and Firenze when she’s not sailing at Martha’s Vineyard or posing with Victoria Beckham, married the eldest Soros spawn in an exclusive 2020 affair at Connecticut’s famed Glass House that was featured in Vogue.

Robert, 63, whose messy $350 million divorce with his first wife Melissa Schiff — after he had an affair with a nude model — almost cost him his art collection, runs family office Soros Capital Management.

Even Robert’s children, George Soros’ grandchildren, Yale-educated tech founder Julien Soros, 30, and New York University MFA-MBA grad and filmmaker Eliza Soros, 32, have started getting involved in the family’s political business, together donating $2,200 so far this cycle.

And on the West Coast, George’s Hollywood movie producer nephew Jeffrey Soros, 66, who’s behind Hulu’s “Legacy: The True Story of the LA Lakers” with Magic Johnson and made films with Alec Baldwin and Jim Carrey, coughed up $12,500, while his mother Daisy Soros, 96, who married George’s brother Paul, chipped in $7,000.

Julien Soros, 30, donated $1,700 to Dem Michigan House candidate Eric Chung.Linkedin / Julien Soros
Hollywood movie producer and George Soros nephew Jeffrey Soros, here with wife Catherine, also donated to Dems.FilmMagic
Patriarch George Soros, 95, handed over the reins of his $25 billion empire to his son Alex in 2023.Bloomberg via Getty Images

The other family members are backing a slew of Democratic midterm candidates that include:

Controversial Democratic candidate for US Senate in Michigan Abdul El-Sayed, who this week received the endorsement of “Squad” Rep. Alexandria Ocasio-Cortez (D-NY), and who’s claimed Israel is “just as evil” as Hamas and refused to condemn Iran’s slain supreme leader.

Alex Soros, 40, funneled a staggering $103M into the midterms so far, mostly through political action committees in his father’s and his names — on track to beat the election spending record set by George in last midterms.

The fourth of George’s five children, who’s been likened to Roman Roy of Succession in a New York Magazine profile last year and is regularly spotted at New York Knicks games in his signature thick-frame glasses or partying in the Hamptons, married Former Hillary Clinton aide and Anthony Weiner ex-wife Huma Abedin in a glamorous Hamptons wedding last summer and has claimed he’s even “more political’’ than his lefty dad.

https://nypost.com/2026/07/04/us-news/members-of-soros-clan-pouring-money-into-house-senate-races/